VOLUME 63 2002 NUMBER 9
CME Pretest 755
CME Posttest 847
Issue to be mailed September 23, 2002
Brainstorms
756 Don't Ask, Don't Tell, but Benzodiazepines Are Still the Leading Treatments
for Anxiety Disorder. Stephen M. Stahl
[PDF]
Original Articles
758 Incident Diabetes Associated With Antipsychotic Use in the United Kingdom
General Practice Research Debate. Cynthia J. Kornegay, Catherine Vasilakis-Scaramozza,
and Hershel Jick
[Abstract]
[PDF]
763 Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients
With Schizophrenia and Schizoaffective Disorder. John M. Kane, William H. Carson,
Anutosh R. Saha, Robert D. McQuade, Gary G. Ingenito, Dan L. Zimbroff, and Mirza
W. Ali
[Abstract]
[PDF]
772 A Randomized, Double-Blind, Placebo-Controlled Study of the Effects of
Adjunctive Paroxetine in
Panic Disorder Patients Unsuccessfully Treated With Cognitive-Behavioral Therapy
Alone. Mirjam Kampman, Ger P. J. Keijsers, Cees A. L. Hoogduin, and Gert-Jan
Hendriks
[Abstract]
[PDF]
778 A Randomized Controlled Trial of Fluvoxamine in Prostatodynia, a Male Somatoform
Pain Disorder. Douglas Turkington, John B. F. Grant, Ian Nicol Ferrier, N.
Sanjay K. Rao,
Keith R. Linsley, and Allan H. Young
[Abstract]
[PDF]
782 Effectiveness and Feasibility of a Standardized Stepwise Drug Treatment
Regimen Algorithm for Inpatients With Depressive Disorders: Results of a 2-Year
Observational Algorithm Study. [CME] Mazda Adli, Anne Berghofer, Michael
Linden, Hanfried Helmchen, Bruno Muller-Oerlinghausen, Arthur Mackert, Thomas
Stamm, and Michael Bauer
[Abstract]
[PDF]
791 The Association Between Substance Abuse and Antidepressant-Induced Mania
in Bipolar Disorder:
A Preliminary Study. [CME] Joseph F. Goldberg and Joyce E. Whiteside
[Abstract]
[PDF]
796 Citalopram Intravenous Infusion in
Resistant Obsessive-Compulsive Disorder: An Open Trial. Stefano Pallanti, M.D.;
Leonardo Quercioli, M.D.; and Lorrin M. Koran, M.D.
[Abstract]
[PDF]
802 Venlafaxine Treatment of Binge-Eating Disorder
Associated With Obesity: A Series of 35 Patients. Shishuka Malhotra, M.D.; Karen H. King, R.N., M.S., C.N.S.; Jeffrey A. Welge, Ph.D.;
Lori Brusman-Lovins, M.S.W.; and Susan L. McElroy, M.D.
[Abstract]
[PDF]
807 Subsyndromal Depression Is Associated With Functional Impairment in Patients
With Bipolar Disorder. Lori L. Altshuler, Michael J. Gitlin, Jim Mintz, Kristin
L. Leight, and Mark A. Frye
[Abstract]
[PDF]
812 The Association Between High Nicotine Dependence and Severe Mental Illness
May Be Consistent Across Countries. Jose de Leon, Elisardo Becona, Manuel
Gurpegui, Ana Gonzalez-Pinto, and Francisco J. Diaz
[Abstract]
[PDF]
817 Use of Psychotropic Medication in the General Population of France, Germany,
Italy, and the United Kingdom. Maurice M. Ohayon and Malcolm H. Lader
[Abstract]
[PDF]
826 Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches
and Treatment Options. Robert M. A. Hirschfeld, Stuart A. Montgomery, Eugenio
Aguglia, Mario Amore, Pedro L. Delgado, Markus Gastpar, Christopher Hawley,
Siegfried Kasper, Michael Linden, Juan Massana, Julien Mendlewicz, Hans-Jurgen
Moller, Charles B. Nemeroff, Jeronimo Saiz, Pedro Such, Riccardo Torta, and
Marcio Versianix
[Abstract]
[PDF]
Letters To the Editor
838 Venlafaxine in a Patient With Idiopathic Leukopenia and Mirtazapine-Induced
Severe Neutropenia. Ion Anghelescu, Christoph Klawe, Norbert Dahmen
[PDF]
838 Obsessive-Compulsive Disorder With Non-24-Hour Sleep-Wake Syndrome.
Shigeru Morinobu,
Hidehisa Yamashita, Shigeto Yamawaki, Kazuhide Tanaka, Masako Ohkawa
[PDF]
840 Injection of Depot Antipsychotic Medications in Patients With Schizophrenia. Martin Fleishman
[PDF]
- Reply by Yuval Bloch
Book Reviews 843
NOW@Psychiatrist.com 849
Information for authors
see July 2002, pages 591-593 or our Web site at www.psychiatrist.com/author.htm